Colchicine to protect neck arteries after radiation for head and neck cancer
Treatments studied
Part of Cancer clinical trials.
This trial tests whether colchicine, an anti-inflammatory medicine, can reduce damage to the carotid arteries (the main blood vessels in the neck) caused by radiation therapy. It may help prevent future stroke or other vascular problems for people who have completed radiation for head and neck cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have been diagnosed with head and neck cancer (mouth, throat, voice box, nose, or salivary glands)
- You finished curative radiation therapy to the neck within the last 18 months
- Your cancer has not come back based on imaging done 3-6 months after radiation
- You are generally able to care for yourself (ECOG 0-2)
- You are not taking colchicine already and are not allergic to it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether patients with early-stage oral cancer who have surgery and lymph-node removal can skip radiation to the neck if certain favorable conditions are met. The goal is to reduce side effects like difficulty swallowing while keeping cancer control strong.
This trial tests whether a special nutritional supplement can help maintain your nutrition and immune system during radiation therapy for head and neck cancer. It aims to reduce side effects and improve your overall health during treatment.
This trial tests a new way of giving radiation therapy, called adaptive radiation boost, for people with head and neck cancer. The goal is to see if this approach can better target the cancer and possibly improve outcomes.
This study tests whether giving lower doses of radiation and chemotherapy is safe and effective for people with certain head and neck cancers. It aims to reduce side effects while keeping the treatment successful.
This trial tests whether giving radiation therapy in a specific way (compartmentalized) after surgery for head and neck cancer is safe and effective. It is for people with certain types of head and neck cancer that have been removed, and aims to improve outcomes while managing side effects.
This study tests two medicines—pravastatin (a statin) and a combination of pentoxifylline and Vitamin E—to see if they can prevent long-term swelling (lymphedema) and scarring in the neck after radiation therapy for throat cancer. Participants receive one of the medicines daily for 2 years, and regular scans help monitor any changes.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.